2C-T-17

2C-T-17 is a psychedelic drug and phenethylamine of the 2C family. It was first synthesized by Alexander Shulgin and documented in his book PiHKAL (Phenethylamines I Have Known And Loved).

History

2C-T-17 was first synthesized and studied by Alexander Shulgin, a renowned chemist and psychopharmacologist. Shulgin's work on the 2C family of drugs has been influential in the field of psychopharmacology, and his findings on 2C-T-17 were published in his book PiHKAL.

Chemistry

2C-T-17 is a phenethylamine, which is a class of drugs that also includes mescaline and amphetamine. It is part of the 2C family, which is characterized by the presence of two carbon atoms between the amine group and the phenyl ring. The 'T' in 2C-T-17 stands for "thio", referring to the sulfur atom in the molecule, and the '17' refers to the seven carbon chain attached to the nitrogen atom.

Effects

The effects of 2C-T-17 are similar to other psychedelic drugs. It is known to produce changes in perception, mood, and thought. Users may experience visual hallucinations, altered states of consciousness, and heightened sensory experiences. The duration of effects typically lasts between 6 to 10 hours.

Legal Status

The legal status of 2C-T-17 varies by country. In the United States, it is classified as a Schedule I controlled substance, making it illegal to manufacture, distribute, or possess. Other countries have similar laws, although the specifics may vary.

Health Risks

As with any psychedelic drug, 2C-T-17 carries potential health risks. These can include psychological distress, such as anxiety and paranoia, as well as physical risks like increased heart rate and blood pressure. It is also possible for users to have a bad reaction to the drug, known as a "bad trip".

See Also

• 2C-T-2
• 2C-T-7
• 2C-T-21
• Psychedelic drug
• Alexander Shulgin
• PiHKAL

2C-T-17 Resources
Latest articles Most recent articles Ongoing trials	Wikipedia